Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action

The use of pharmaceuticals for colon cancer treatment has been increasingly personalized, in part due to the development of new molecular tools. In this review, we discuss the old and new colon cancer chemotherapeutics, and the parameters that have been shown to be predictive of efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Kline, Christina Leah B., El-Deiry, Wafik S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817731/
https://www.ncbi.nlm.nih.gov/pubmed/24276379
http://dx.doi.org/10.3390/ph6080988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817731/
https://www.ncbi.nlm.nih.gov/pubmed/24276379
http://dx.doi.org/10.3390/ph6080988

Ejemplares similares